Perda de seguimento do tratamento da tuberculose na infância e adolescência: análise dos fatores associados

Luís Felipe Lopes de Melo; Tiago Silva Peixoto; Ricardo Alves de Olinda; Jânia Cristiane de Souza Oliveira; Jacqueline Pimenta Navarro da Silva; Letícia Silveira Goulart

doi:10.36517/2175-6783.20252695905

Autores

Luís Felipe Lopes de Melo Universidade Federal de Rondonópolis https://orcid.org/0009-0000-4176-2827
Tiago Silva Peixoto Universidade Federal de Rondonópolis https://orcid.org/0000-0001-6951-6679
Ricardo Alves de Olinda Universidade Estadual da Paraíba https://orcid.org/0000-0002-0509-8428
Jânia Cristiane de Souza Oliveira Universidade Federal de Rondonópolis https://orcid.org/0000-0003-4035-2492
Jacqueline Pimenta Navarro da Silva Universidade Federal de Rondonópolis https://orcid.org/0000-0002-1967-9290
Letícia Silveira Goulart Universidade Federal de Rondonópolis https://orcid.org/0000-0003-1452-4908

DOI:

https://doi.org/10.36517/2175-6783.20252695905

Palavras-chave:

Tuberculose; Criança; Adolescente; Pacientes Desistentes do Tratamento; Fatores de Risco.

Resumo

Objetivo: analisar os fatores associados à perda de seguimento do tratamento da tuberculose na infância e adolescência. Métodos: estudo retrospectivo e analítico. A população foi constituída por todos os casos novos de tuberculose, de 0 a 19 anos de idade. Os dados foram coletados do Sistema Informação de Agravos de Notificação. Foi realizada uma regressão linear múltipla para estimar a associação entre as variáveis sociodemográficas, clínico-epidemiológicas e terapêuticas com a perda de seguimento do tratamento. Resultados: a proporção da perda de seguimento do tratamento foi de 8,0%. Os fatores associados foram a não realização de raio X (p < 0,001), do teste de HIV (p = 0,002) e do tratamento diretamente observado (p < 0,001). Conclusão: os achados indicam a necessidade para adoção de estratégias abrangentes para reduzir a perda de seguimento do tratamento de tuberculose em crianças e adolescentes, como ampliar a oferta de serviços de diagnóstico e acompanhamento de tuberculose, além de fortalecer o vínculo dos profissionais de saúde com os familiares dessa população. Contribuições para a prática: recomenda-se a ampliação da realização dos testes de HIV e radiografia de tórax. É essencial a intensificação do tratamento diretamente observado, inclusive com uso de tecnologias digitais.

Downloads

Não há dados estatísticos.

Referências

1. Silva MT, Galvão TF. Tuberculosis incidence in Brazil: time series analysis between 2001 and 2021 and projection until 2030. Rev Bras Epidemiol. 2024;27:e240027. doi: https://dx.doi.org/10.1590/1980-549720240027

2. Tahan TT, Gabardo B, Rossoni AM. Tuberculosis in childhood and adolescence: a view from different perspectives. J Pediatr (Rio J). 2020;96(sppl 1):99-110. doi: https://dx.doi.org/10.1016/j.jped.2019.11.002

3. Peres TG, Castro YM, Corrêa ML, Emmendorfer LR, Zhang L. Trends in tuberculosis mortality among children and adolescents in Brazil, 1996-2020: a joinpoint analysis. J Bras Pneumol. 2023;49:e20230019. doi: https://dx.doi.org/10.36416/1806-3756/e20230019

4. Linn AR, Dubois MM, Steenhoff AP. Under-reporting of tuberculosis disease among children and adolescents in low and middle-income countries: a systematic review. Trop Med Infect Dis. 2023; 8(6):300. doi: https://dx.doi.org/10.3390/tropicalmed8060300

5. Santos BA, Cruz RP, Lima SV, Santos AD, Duque AM, Araújo KC, et al. Tuberculosis among children and adolescents: an epidemiological and spatial analysis in the state of Sergipe, Brazil, 2001-2017. Ciênc Saúde Colet. 2020;25(8):2939-48. doi: https://doi.org/10.1590/1413-81232020258.25692018

6. Leddy AM, Jaganath D, Triasih R, Wobudeya E, Oliveira MCB, Sheremeta Y, et al. Social determinants of adherence to treatment for tuberculosis infection and disease among children, adolescents, and young adults: a nar-rative review. J Pediatric Infect Dis Soc. 2022;11(Suppl 3):79-84. doi: https://doi.org/10.1093/jpids/piac058

7. Soledade MP, Yamauti SM, Aguiar AS, Sucupira C, Crozatti MTL. Tuberculosis in childhood and adolescence: prevalence and factors associated with treatment abandonment. Cad Saúde Pública. 2024;40(9):e00158323. doi: http://doi.org/10.1590/0102-311XPT158323

8. Instituto Brasileiro de Geografia e Estatística (IBGE). Mato Grosso - panorama [Internet]. 2022 [cited Jun 3, 2025]. Available from: https://www.ibge.gov.br/cidades-e-estados/mt.html

9. Ministério da Saúde (BR). Saúde do adolescente e jovens [Internet]. 2025 [cited Aug 11, 2025]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/s/saude-do-adolescente

10. Ministério da Saúde (BR). Manual de Recomendações para o Controle de tuberculose no Brasil [Internet]. 2024 [cited Jun 6, 2025]. Available from: http://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/tuberculose/manual-de-recomendacoes-e-controle-da-tuberculose-no-brasil-2a-ed.pdf/view

11. Ministério da Saúde (BR). DATASUS. TABNET. [Internet]. 2024 [cited Aug 19, 2025]. Available from: http://datasus.saude.gov.br/transferencia-de-arquivos/

12. World Health Organization (WHO). Global tuberculosis report 2024 [Internet]. 2024 [cited Jun 26, 2025]. Available from: https://www.who.int/publications/i/item/9789240101531

13. Chenciner L, Annerstedt KS, Pescarini JM, Wingfield T. Social and health factors associated with unfavourable treatment outcome in adolescents and young adults with tuberculosis in Brazil: a national retrospective cohort study. Lancet Glob Health. 2021;9:e1380-90. doi: https://doi.org/10.1016/S2214-109X(21)00300-4

14. Siamisang K, Rankgoane-Pono G, Madisa TM, Mudiayi TK, Tlhakanelo JT, Mubiri P, et al. Pediatric tuberculosis outcomes and factors associated with unfavorable treatment outcomes in Botswana, 2008-2019: a retrospective analysis. BMC Public Health. 2022;4(22)2020. doi: https://doi.org/10.1186/s12889-022-14477-y

15. Yuen CM, Szkwarko D, Dubois MM, Shahbaz S, Yuengling KA, Urbanowski ME, et al. Tuberculosis care models for children and adolescents: a scoping review. Bull World Health Organ. 2022;1,100(12):777-88. doi: https://doi.org/10.2471/BLT.22.288447

16. Gunsaru V, Henrion MYR, McQuaid CF. The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries. BMC Med. 2024;22(1):312. doi: https://doi.org/10.1186/s12916-024-03532-7

17. Braga RS, Ferreira MRL, Orfão NH. Impacts of Covid-19 on tuberculosis: an integrative review. Mundo Saúde. 2024;48:e16232024. doi: http://doi.org/10.15343/0104-7809.202448e16232024P

18. Santos JC, Silva JB, Rangel MA, Barbosa L, Carvalho I. Preventive therapy compliance in pediatric tuberculosis - a single center experience. Pulmonology. 2020;26(2):78-83. doi: https://dx.doi.org/10.1016/j.pulmoe.2019.06.002

19. Perlaza CL, Mosquera FEC, Murillo LMR, Sepulveda VB, Arenas CDC. Factors of abandonment of tuberculosis treatment in the public health network. Rev Saúde Pública. 2023;57:8. doi: https://doi.org/10.11606/s1518-8787.2023057004454

20. Lima LV, Pavinati G, Palmieri IGS, Vieira JP, Blasque JC, Higarashi IH, et al. Factors associated with loss to follow-up in tuberculosis treatment in Brazil: a retrospective cohort study. Rev Gaúcha Enferm. 2023;44:e20230077. doi: https://doi.org/10.1590/1983-1447.2023.20230077.en

21. Ferreira MRL, Bonfim RO, Siqueira TC, Orfão NH. Risk factors for the abandonment of tuberculosis treatment in an amazonian priority municipality. Rev Pesq Cuid Fundam Online. 2021;13:185-91. doi: http://dx.doi.org/10.9789/2175-5361.rpcfo.v13.8133

22. MacPherson P, Webb EL, Kamchedzera W, Joekes E, Mjoli G, Lallo DG, et al. Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis. PLoS Med. 2021;18(9):e1003752. doi: https://doi.org/10.1371/journal.pmed.1003752

23. Cola JP, Prado TN, Sales CMM, Maciel ELN. Family Health Strategy and determinants of directly observed treatment for tuberculosis in Brazil: a cross-sectional study with surveillance system data, 2014-2016. Epidemiol Serv Saúde. 2020;29(5):e2020284. doi: https://doi.org/10.1590/S1679-49742020000500010

24. Lucena LA, Dantas GBS, Carneiro TV, Lacerda HG. Factors associated with the abandonment of tuberculosis treatment in Brazil: a systematic review. Rev Soc Bras Med Trop. 2023;56:e0155–2022. doi: https://doi.org/10.1590/0037-8682-0155-2022

25. Sousa GJB, Maranhão TA, Leitão TMJS, Moreira TMM, Souza JT, Pereira MLD. Prevalence of drug-resistant tuberculosis and associated factors. Rev Rene. 2021;22:e70733. doi: https://dx.doi.org/10.15253/2175-6783.20212270733

26. Távora MM, Rodrigues ILA, Nogueira LMV, Silva FO. Perceptions of nurses and patients on adherence to the directly observed treatment in tuberculosis. Cogitare Enferm. 2021;26:e69930. doi: https://doi.org/10.5380/ce.v26i0.69930

27. Junges JR, Burille A, Tedesco J. Directly Observed Therapy for treating tuberculosis: critical analysis of decentralization. Interface (Botucatu). 2020; 24:e190160. doi: https://doi.org/10.1590/Interface.190160

28. Adário KDO, Oliveira RCC, Videres ARN, Henriques AHB, Palha PF, Barrêto AJR. Policy transfer of the directly observed treatment of tuberculosis: speeches of health managers. Rev Gaúcha Enferm. 2021;42:e20200427. doi: https://dx.doi.org/10.1590/1983-1447.2021.20200427

29. Santos MMR, Costa BVM, Rodrigues MCB, Cardoso CA. Barriers and facilitators of adherence to tuberculosis treatment in children and adolescentes. Resid Pediatr. 2024;14(1):1-8. doi: https://doi.org/10.25060/residpediatr-2024.v14n1-1021

30. Baluku JB, Kabamooli RA, Kajumba N, Nabwana M, Kateete D, Kiguli S, et al. Contact tracing is associated with treatment success of index tuberculosis cases in Uganda. Int J Infect Dis. 2021;109:129-36. doi: https://dx.doi.org/10.1016/j.ijid.2021.06.049